Intelligence Β· Patent portfolio
Takeda Patents
Full USPTO pharma patent portfolio for Takeda β grant dates, expiration, and drug cross-links.
- Patents
- 1,436
- Expiring β€24m
- 81
Quick answer
Takeda has 1,436 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 81 expire within 24 months β use filters for patent-cliff planning.
-
US 6166043
Pharmaceutical composition
expired -
US 6166042
Pharmaceutical composition
expired -
US 6162828
Cysteine protease inhibitor
expired -
US 6156773
Pharmaceutical composition
expired -
US 6150383
Pharmaceutical composition
expired -
US 6150384
Pharmaceutical composition
expired -
US 6147071
Cyclic compounds, their production and use
expired -
US 6147051
Methods and compositions for the prophylactic and/or therapeutic treatment of organ hypofunction
expired -
US 6147099
Oxazolidinedione derivatives, their production and use
expired -
US 6136781
LH-RH receptor antagonists
expired -
US 6133293
Pharmaceutical composition
expired -
US 6133278
Use of quinone and hydroquinone derivatives for the treatment of cachexia
expired -
US 6133295
Pharmaceutical composition
expired -
US 6123962
Process for producing stabilized pharmaceutical composition
expired -
US 6121295
Pharmaceutical composition
expired -
US 6121294
Pharmaceutical composition
expired -
US 6117455
Sustained-release microcapsule of amorphous water-soluble pharmaceutical active agent
expired -
US 6117645
Human LH-RH receptor expression cells and use thereof
expired -
US 6113941
Substained release microcapsule of physiologically active compound which is slightly water soluble at pH 6 to 8
expired -
US 6113943
Sustained-release preparation capable of releasing a physiologically active substance
expired -
US 6111076
Human G-protein coupled receptor (HIBCD07)
expired -
US 6110948
Anticachectic composition
expired -
US 6110909
Benzoxazepine compounds, their production and use as lipid lowering agents
expired -
US 6107323
Pharmaceutical composition
expired -
US 6103742
Pharmaceutical composition
expired -
US 6100252
Heterocyclic compounds and their use as angiotensin antagonists
expired -
US 6096780
Quaternary ammonium salts and their use
expired -
US 6087324
Sustained-release preparation
expired -
US 6087384
Apoptosis inhibitor
expired -
US 6083916
Pharmaceutical product for application to uterus mucosa
expired -
US 6080765
Pharmaceutical composition
expired -
US 6068990
Proteins, their production and use
expired -
US 6051240
Method of separating protective components of Bordetella pertussis
expired -
US 6048711
Human G-protein coupled receptor polynucleotides
expired -
US 6045830
Method of production of sustained-release preparation
expired -
US 6040324
Prophylactic or therapeutic drug for renal diseases
expired -
US 6036976
Sustained release microspheres and preparation thereof
expired -
US 6030967
Naphtholactams and lactones as bone morphogenetic protein active agents
expired -
US 6025467
Parathyroid hormone derivatives and their use
expired -
US 6022564
Method for producing a microparticle
expired -
US 6017560
Process for producing stabilized pharmaceutical composition
expired -
US 6015552
Use of nerve growth factor-2 (NGF-2) /neurotrophin-3 (NT-3) to promote leukocyte proliferation
expired -
US 6015789
Combined use of GnRH agonist and antagonist
expired -
US 6013762
Smooth muscle mitogen and isolated DNA coding therefor
expired
Frequently asked questions
How many patents does Takeda have?
1,436 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Takeda patents expire?
81 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.
Where does this data come from?
USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.
Data attribution: Data sources Β· Patent directory